FLUIDIA is a start-up that develops and commercializes a new generation of molecular tests to diagnose different types of diseases. The new technology that FLUIDIA has developed and patented makes it possible to evaluate the shape of any biomarker protein quickly and economically. The start-up has applied this innovative technology to a biomarker common to the main cancers, thus making it possible to develop an early detection test that will be introduced on the market in 2020.

Website : www.fluidiabiotech.com

Call 2020

The 2020 Call for Application is now close. Stay tuned for the 2021 Call



Receive notifications about the YEi Start in France program (Call for applications, announcement of the laureates, YEi events, etc.)

Social Links